Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

1 729 evidences · page 22 / 70

72 %The pooled ART retention rate among people living with HIV in Nigeria was 72%.

NigeriaVIH/sidapublié 2024Journal of research in health sciencesPubMeddocument de 5 observations

5,2 %18 (5.2%) of the participants correctly responded that family should be involved in the physical care of the dying people living with HIV/AIDS.

NigeriaVIH/sidaobservé 2017publié 2019PloS onePubMeddocument de 16 observations

27,1 %The prevalence of TB/HIV coinfection was highest in 2021 at 27.1%.

Nigeriatuberculose · VIH/sidaobservé 2021publié 2024BMJ openPubMeddocument de 6 observations

10,8 yearsThe mean age of the HIV-infected children on HAART was 10.8 ± 4.3 years.

NigeriaVIH/sidapublié 2025African health sciencesPubMeddocument de 7 observations

Stigma and criminalization create barriers to health-care engagement and adherence to antiretroviral therapy (ART) among men who have sex with men (MSM) and transgender women (TGW) in sub-Saharan Africa.

NigeriaVIH/sidapublié 2019Antiviral therapyPubMeddocument de 6 observations

Antioxidant status was improved in the HIV-infected group on antiretroviral therapy (ART).

NigeriaVIH/sidapublié 2019BMC infectious diseasesPubMeddocument de 7 observations

0,4 %The prevalence of Cytomegalovirus (CMV) retinitis among persons living with HIV/AIDS in Osun State, Nigeria was 0.4%.

NigeriaCytomegalovirus (CMV) retinitis · VIH/sidapublié 2026BMC ophthalmologyPubMeddocument de 9 observations

4,3 %The prevalence of HIV among adolescents aged 10 to 19 years seeking healthcare services at the Federal Teaching Hospital, Birnin Kebbi, Nigeria, was 4.3% between January and June 2023.

NigeriaVIH/sidaobservé January and June 2023publié 2025African journal of reproductive healthPubMeddocument de 4 observations

93 %Viral suppression among people living with HIV on antiretroviral therapy for ≥6 months was 93% during the COVID-19 pandemic (51,196/55,216) compared to 91% in the pre-COVID-19 period (43,336/47,728).

NigeriaVIH/sidaobservé during COVID-19publié 2024PloS onePubMeddocument de 7 observations

50 %Fewer than half of facilities reported achieving rates of ≥90% completion of post-breastfeeding HIV testing for infants.

NigeriaVIH/sidapublié 2025Journal of the International Association of Providers of AIDS CarePubMeddocument de 3 observations

71 %Among 1598 female sex workers in Nigeria, 71.0% had HIV testing during their last pregnancy.

NigeriaVIH/sidapublié 2024International journal of STD & AIDSPubMeddocument de 12 observations

55,6 %Viral load suppression rates through adolescence and post-transition were 55.6%–64.0%.

NigeriaVIH/sidapublié 2020PloS onePubMeddocument de 7 observations

81,2 %Five hundred forty-nine (81.2%) of 676 tuberculosis patients at the TB DOTS clinic of Abubakar Tafawa Balewa University Teaching Hospital, Bauchi, from January 2017 to December 2021 were HIV negative.

NigeriaVIH/sidaobservé 2017 to 2021publié 2024West African journal of medicinePubMeddocument de 14 observations

60,8 %60.8% of community-identified children living with HIV came from community-based index testing.

NigeriaVIH/sidapublié 2023BMC pediatricsPubMeddocument de 10 observations

1 individualsAmong those tested for HIV in the medical outreach in Durum community, Bauchi State, Nigeria, 1 (1%) had a positive result.

NigeriaVIH/sidaobservé 2023publié 2023West African journal of medicinePubMeddocument de 11 observations

1 000 copies/mLThe intervention showed a significant effect on virologic control <1000 copies per milliliter (odds ratio = 1.42).

NigeriaVIH/sidapublié 2025Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 7 observations

37,5 %CRF02_AG was the major HIV-1 subtype, accounting for 37.5% of cases.

NigeriaVIH/sidaobservé 2009-12publié 2016PloS onePubMeddocument de 14 observations

87,5 %Retention in care at 48 weeks was 87.5% among youth with HIV in Nigeria in a single-arm trial.

NigeriaVIH/sidapublié 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument de 12 observations

0,12 %Among 2386 initially uninfected pregnant women in Nigeria followed until delivery, the seroconversion rate for HIV-HBV dual infection was 0.12%.

Nigeriahépatite B · VIH/sidapublié 2025Antiviral therapyPubMeddocument de 7 observations

Comprehensive HIV/AIDS knowledge remains low among young people in Nigeria.

NigeriaVIH/sidapublié 2025AIDS research and therapyPubMeddocument de 5 observations

159 casesThe study evaluated 159 cases of acquired drug resistance among persons living with HIV receiving combination antiretroviral therapy.

NigeriaVIH/sidaobservé 2004–2011publié 2020AIDS research and therapyPubMeddocument de 7 observations

60 %The total knowledge score of HIV PEP among doctors was 60.0% with a standard deviation of 10.2%.

NigeriaVIH/sidapublié 2020West African journal of medicinePubMeddocument de 6 observations

12 %Low birth weight occurred in 12.0% of HIV-exposed babies and 13.5% of non-exposed babies.

NigeriaVIH/sidaobservé 2009-2015publié 2019West African journal of medicinePubMeddocument de 4 observations

Adherence to Option B+ ART can reduce the risk of mother-to-child transmission (MTCT) of HIV to 1-2% as against 15-40% without treatment.

NigeriaVIH/sidapublié 2021The Pan African medical journalPubMeddocument de 5 observations

75,6 %75.6% of subjects receiving HIV treatment in private facilities in the Federal Capital Territory, Benue, and Nasarawa states in north-central Nigeria were virally suppressed.

NigeriaVIH/sidaobservé 2013–2019publié 2022AIDS research and therapyPubMeddocument de 3 observations

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.